» Articles » PMID: 17680361

The Expression of NMDA Receptor Subunits in Cerebral Cortex and Hippocampus is Differentially Increased by Administration of Endobain E, a Na+, K+-ATPase Inhibitor

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2007 Aug 8
PMID 17680361
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies showed that endobain E, an endogenous Na+, K+-ATPase inhibitor, decreases dizocilpine binding to NMDA receptor in isolated membranes. The effect of endobain E on expression of NMDA receptor subunits in membranes of rat cerebral cortex and hippocampus was analyzed by Western blot. Two days after administration of 10 mul endobain E (1 microl = 29 mg fresh tissue) NR1 subunit expression enhanced 5-fold and 2.5-fold in cerebral cortex and hippocampus, respectively. NR2A subunit expression increased 2-fold in cerebral cortex and 1.5-fold in hippocampus. The level of NR2B subunit raised 3-fold in cerebral cortex but remained unaltered in hippocampus. NR2C subunit expression was unaffected in either area. NR2D subunit enhanced 1.6 and 2.1-fold for cerebral cortex and hippocampus, respectively. Results indicate that endogenous Na+, K+-ATPase inhibitor endobain E differentially modifies the expression of NMDA receptor subunits.

Citing Articles

The Involvement of Glial Cells in Blood-Brain Barrier Damage in Neuroimmune Diseases.

Nagata S, Yamasaki R Int J Mol Sci. 2024; 25(22).

PMID: 39596390 PMC: 11594741. DOI: 10.3390/ijms252212323.


Ouabain Modulates the Functional Interaction Between Na,K-ATPase and NMDA Receptor.

Akkuratov E, Westin L, Vazquez-Juarez E, de Marothy M, Melnikova A, Blom H Mol Neurobiol. 2020; 57(10):4018-4030.

PMID: 32651756 PMC: 7467916. DOI: 10.1007/s12035-020-01984-5.


Na/K-pump and neurotransmitter membrane receptors.

Pivovarov A, Calahorro F, Walker R Invert Neurosci. 2018; 19(1):1.

PMID: 30488358 PMC: 6267510. DOI: 10.1007/s10158-018-0221-7.


Effect of NMDA on proliferation and apoptosis in hippocampal neural stem cells treated with MK-801.

Ding J, Shao Y, Zhou H, Ma Q, Zhang Y, Ding Y Exp Ther Med. 2018; 16(2):1137-1142.

PMID: 30116364 PMC: 6090289. DOI: 10.3892/etm.2018.6346.


Are Polyunsaturated Fatty Acids Implicated in Histaminergic Dysregulation in Bipolar Disorder?: AN HYPOTHESIS.

Riveros M, Retamal M Front Physiol. 2018; 9:693.

PMID: 29946266 PMC: 6005883. DOI: 10.3389/fphys.2018.00693.


References
1.
Brown D, Krupp J . N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics. Curr Top Med Chem. 2006; 6(8):749-70. DOI: 10.2174/156802606777057571. View

2.
Beal M . Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 1992; 6(15):3338-44. View

3.
Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P . NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke. 2006; 37(7):1895-901. DOI: 10.1161/01.STR.0000226981.57777.b0. View

4.
Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M . Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem. 1993; 268(4):2836-43. View

5.
Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View